(IN BRIEF) In a significant development for Africa’s pharmaceutical sector, the African Pharmaceutical Technology Foundation and the Rwandan Government have signed a host country agreement, paving the way for the Foundation’s operationalization. The Foundation has also forged a memorandum of … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Pharma & Biotech, Technology
Tagged Africa, African Development Bank, African Pharmaceutical Industry, African Pharmaceutical Technology Foundation, Dr Akinwumi Adesina, Dr Bärbel Kofler, Dr Ngozi Okonjo-Iweala, Dr Tedros Adhanom Ghebreyesus, Dr Vincent Biruta, EIB, Gelsomina Vigliotti, partnership, Professor Padmashree Gehl Sampath, sustainability
(IN BRIEF) Roche (SIX: RO, ROG; OTCQX: RHHBY) has once again secured its position as one of the leading sustainable companies in the Pharmaceuticals sector within the Dow Jones Sustainability Indices (DJSI). In the latest rankings, Roche secured the third … Read the full press release
(IN BRIEF) The European Investment Bank (EIB) has signed a €20 million venture debt financing agreement with The Akkermansia Company, a Belgian microbiome health specialist, supported by the European Commission’s InvestEU initiative. The Akkermansia Company, originating as a spin-off from … Read the full press release
Posted in Banks, Belgium, Business, Economy, Environment, Financial, Government, Industrial, Investment, Luxembourg, Management, News, Pharma & Biotech, Science, Technology
Tagged Akkermansia Company, Belgium, EIB, financing, Kris Peeters, Michael Oredsson, Microbiome Health Research, partnership, sustainability
(IN BRIEF) Novadip, a Belgian biotech company, has secured €18 million in venture debt financing from the European Investment Bank (EIB) with support from the European Union’s InvestEU initiative. The funds will be utilized for clinical trials of NVD-003, an … Read the full press release
(IN BRIEF) Novozymes and Chr. Hansen have unveiled their new collective name, ‘Novonesis,’ symbolizing a fresh beginning in the world of biosolutions. This announcement marks a significant step towards the merger of the two companies. Novonesis, which means ‘A new … Read the full press release
Posted in Business, Denmark, Industrial, Management, News, Pharma & Biotech, Science, Technology
Tagged 'Novonesis', biology, biosolutions, Cees de Jong, Chr. Hansen, Ester Baiget, Novozymes, partnership
(IN BRIEF) Roche, a global pharmaceutical company, has shared compelling data from its CD20xCD3 T-cell engaging bispecific antibody program during the 65th American Society of Hematology (ASH) Annual Meeting & Exposition held in December 2023. The data includes extended follow-up … Read the full press release
(IN BRIEF) In a significant development, GSK plc has received marketing authorization from the European Commission (EC) for Jemperli (dostarlimab) in combination with carboplatin-paclitaxel chemotherapy as a treatment option for adult patients suffering from mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) … Read the full press release
(IN BRIEF) In the Phase 3 IsKia trial presented at the American Society of Hematology (ASH) Annual Meeting, Sarclisa® (isatuximab) combined with carfilzomib, lenalidomide, and dexamethasone (KRd) demonstrated a significant improvement in achieving minimal residual disease (MRD) negativity among newly … Read the full press release
Posted in Business, Education, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged carfilzomib, Combination Therapy, dexamethasone, Francesca Gay, lenalidomide, Myeloma, Peter C. Adamson, Phase 3 Trial, Remission Rates, Sanofi, Sarclisa
(IN BRIEF) Roche has announced promising results from the Phase III INAVO120 study, which evaluated inavolisib in combination with palbociclib (Ibrance®) and fulvestrant as a first-line treatment for individuals with PIK3CA-mutated, hormone receptor (HR)-positive, HER2-negative, endocrine-resistant, locally advanced, or metastatic … Read the full press release
(IN BRIEF) BioNTech, a leading biotechnology company, has formalized a multi-year strategic partnership with the State of Victoria in Australia, building upon a prior Letter of Intent established in October 2022. The collaboration aims to strengthen the local mRNA ecosystem … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Australia, BioNTainers, BioNTech, mRNA Ecosystem, partnership, Prof. Ugur Sahin, Sierk Poetting, sustainability, Victoria
(IN BRIEF) Sanofi is showcasing its ambitious pipeline transformation strategy, which includes a record 12 potential blockbuster opportunities currently under clinical evaluation. Among these, there are nine innovative medicines and vaccines with peak sales potential ranging from €2 to €5 … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Technology
Tagged Houman Ashrafian, Immunology Industry, Paul Hudson, Sanofi
(IN BRIEF) The Phase 3 IMROZ trial, assessing the use of Sarclisa® (isatuximab) in combination with standard-of-care bortezomib, lenalidomide, and dexamethasone (VRd), has achieved its primary efficacy endpoint at a planned interim analysis. The trial demonstrated a statistically significant improvement … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology
Tagged Dietmar Berger, IMROZ trial, Multiple Myeloma Patients, Sanofi, Sarclisa, Thierry Facon
(IN BRIEF) Roche, a leading pharmaceutical company, has announced its definitive merger agreement to acquire Carmot Therapeutics, a privately owned US-based company specializing in obesity treatment and related metabolic diseases. The acquisition includes Carmot’s portfolio of clinical stage subcutaneous and … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged acquisition, Carmot Therapeutics, CT-388, Levi Garraway, metabolic disease, Obesity Treatment, Roche, Thomas Schinecker, USA
(IN BRIEF) Sanofi’s Consumer Healthcare business unit (CHC) has introduced the Shared Care Collective, an advisory board consisting of experts from various fields, both internal and external, to bolster sustainability efforts within the CHC business. This initiative aims to foster … Read the full press release
(IN BRIEF) Krka, a Slovenian pharmaceutical company, has been honored with the TOP Education Management certificate at the Edutainment 2023 convention. This recognition is presented to Slovenian companies that demonstrate a strong commitment to employee education and development. Krka’s Head … Read the full press release
Posted in Awards, Business, Education, Industrial, Management, News, Pharma & Biotech, Slovenia
Tagged Awards, Employee Development, investment, Krka, Simona Torkar Flajnik, TOP Education Management Certificate
(IN BRIEF) AstraZeneca is set to unveil promising data at the 65th American Society of Hematology (ASH) Annual Meeting, highlighting its expanding hematology pipeline and the enduring effectiveness of Calquence in treating chronic lymphocytic leukemia (CLL). The presentation includes six-year … Read the full press release
(IN BRIEF) Novartis, a leading pharmaceutical company, presented its ‘pure play’ innovative medicines strategy and focused Research and Development (R&D) pipeline at an event in London. The company’s CEO, Vas Narasimhan, emphasized Novartis’ transformation into an innovative medicines-focused firm, highlighting … Read the full press release
Posted in Business, Industrial, Management, Media, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged 'Pure Play' Innovative Medicines Strategy, London Event, Novartis, R&D Pipeline, Vas Narasimhan
(IN BRIEF) Boehringer Ingelheim and IBM have formed a partnership to expedite the discovery of novel candidate antibodies for therapeutic purposes. Boehringer will utilize IBM’s foundation model technologies, combining them with their proprietary data to enhance the antibody discovery process. … Read the full press release
(IN BRIEF) Roche has unveiled Elecsys® HBeAg quant, a new immunoassay designed to detect the presence and quantity of the hepatitis B e antigen (HBeAg) in human serum and plasma. This diagnostic tool simplifies the process for both clinicians and … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged diagnosis, Elecsys®, HBeAg Quant Test, Hepatitis B, Matt Sause, monitoring, Roche
(IN BRIEF) GlaxoSmithKline (GSK) has reported positive results from the interim efficacy analysis of the DREAMM-7 phase III trial evaluating belantamab mafodotin as a second-line treatment for relapsed or refractory multiple myeloma. The trial successfully met its primary endpoint of … Read the full press release
(IN BRIEF) In a significant development, the second investigational Phase 3 trial of Dupixent® (dupilumab) for chronic obstructive pulmonary disease (COPD), known as NOTUS, has demonstrated promising results. The trial found that Dupixent reduced COPD exacerbations by 34% compared to … Read the full press release
Posted in Business, Education, France, Healthcare, Management, News, Pharma & Biotech, Science, Technology
Tagged COPD, Dupixent, Exacerbations, George D. Yancopoulos, Naimish Patel, NOTUS, Regeneron, Sanofi
(IN BRIEF) Merck has completed the second phase of its new €29 million Biologics Testing Center in China, adding 1,500 square meters to the facility. This expansion includes the first biosafety laboratories for Merck in the Chinese market, enabling clients … Read the full press release
(IN BRIEF) GSK, a leading pharmaceutical company, has unveiled plans to conduct Phase III trials in 2024 for a low carbon version of its popular inhaler, Ventolin (salbutamol). The initiative aims to reduce greenhouse gas emissions associated with the inhaler’s … Read the full press release
Posted in Business, Environment, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged emissions, Emma Walmsley, GSK, health, Low Carbon Inhaler, respiratory conditions, sustainability, Ventolin
(IN BRIEF) AstraZeneca has introduced Evinova, a groundbreaking venture poised to become a leader in digital health solutions, catering to the needs of healthcare professionals, regulators, and patients. Backed by AstraZeneca and strategically collaborating with Parexel and Fortrea, Evinova is … Read the full press release
Posted in Business, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AstraZeneca, Cristina Duran, digital health solutions, digital technology, Evinova, Fortrea, Healthcare, Parexel, partnership, Pascal Soriot, sustainability
(IN BRIEF) Basilea Pharmaceutica Ltd, a biopharmaceutical company dedicated to addressing severe bacterial and fungal infections, has announced that its antifungal medication, Cresemba® (isavuconazole), has achieved robust sales performance in the Asia Pacific region and China through its licensing partner, … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged Antifungal Drug, Asia Pacific, Basilea, Cresemba®, David Veitch, partnership, Pfizer Inc.
(IN BRIEF) AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has gained approval from the US Food and Drug Administration (FDA) for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer possessing specific … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, United Kingdom
Tagged AstraZeneca, Breast Cancer Treatment, Dave Fredrickson, Faslodex, Komal Jhaveri, Truqap, US FDA
(IN BRIEF) Roche has introduced the Elecsys®Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays for detecting hepatitis E virus (HEV) infections in regions accepting the CE mark. These tests aim to assist clinicians in diagnosing the cause of patients’ symptoms, determining … Read the full press release
(IN BRIEF) The global health NGO Deutsche Stiftung Weltbevölkerung (DSW) is calling on the European Union (EU) to establish a priority review program aimed at encouraging investment in research and innovation (R&I) to combat poverty-related and neglected infectious diseases. Over … Read the full press release
Posted in Belgium, European Union, Healthcare, Non Profit, Pharma & Biotech, Society
Tagged antibodies for HIV, David Reddy, Deutsche Stiftung Weltbevölkerung, DSW, EDCTP, EU priority review programme, European Union, global health, health NGO, Hester Kuipers, IAVI, infectious diseases, Lisa Goerlitz, Malaria Venture, medical need, MMV, neglected infectious diseases, Professor John Reeder, TB, TDR, vaccines, World Health Organization
(IN BRIEF) IQ Biozoom, a medical technology startup, is developing non-invasive home diagnostics that allow people to measure the concentration of biochemical substances in liquid analytes like saliva, sweat, urine, or tears. Their technology integrates inkjet printing with advanced semiconductors, … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Poland, Small Business, Technology
Tagged biomarker, biosensor system, blood glucose, blood glucose meters, Diabetes, endocrine disorders, glucose, glucose monitoring, home diagnostics, home tests, IQ Biozoom, lactate levels, medical technology, medical technology startup, medtech, metabolic disorders, non-invasive home diagnostics, non-invasive home testing, personalised medicine, saliva analysis, sports medicine, startup, VC Link fund
(IN BRIEF) The European Investment Bank (EIB) and Romania’s leading pharmaceutical manufacturer, Antibiotice, have partnered to support the production of medicines in Romania. Through a €25 million loan agreement, the EIB will finance the construction of a modern production, packaging, … Read the full press release
Posted in Banks, Business, Construction, Economy, Environment, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Luxembourg, Management, News, Pharma & Biotech, Romania, Technology
Tagged Antibiotice, European Investment Bank, Healthcare, Ioan Nani, Medicine Production, Paolo Gentiloni, partnership, Romania, sustainability, Teresa Czerwinska
(IN BRIEF) Novo Nordisk has unveiled plans to invest more than 42 billion Danish kroner starting in 2023 to expand its existing manufacturing facilities in Kalundborg, Denmark. This significant investment coincides with the company’s 100th anniversary and underscores Novo Nordisk’s … Read the full press release
(IN BRIEF) Kuehne+Nagel’s North American Road Logistics team received an urgent request from a pharmaceutical customer to deliver 150 pallets of flu vaccines to over 40 Veterans Affairs (VA) hospitals across the U.S. within ten days. The team quickly organized … Read the full press release
(IN BRIEF) AstraZeneca has reported positive high-level results from the EMERALD-1 Phase III trial, demonstrating that its drug Imfinzi (durvalumab), in combination with transarterial chemoembolisation (TACE) and bevacizumab, significantly improves progression-free survival (PFS) in patients with hepatocellular carcinoma (HCC) eligible … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, bevacizumab, Dr. Riccardo Lencioni, EMERALD-1, HCC, Imfinzi, Imfinzi Combination Therapy, Liver Cancer Treatment, Phase III Trial, Susan Galbraith, TACE
(IN BRIEF) AstraZeneca and Eccogene have signed an exclusive license agreement for ECC5004, an investigational oral once-daily glucagon-like peptide 1 receptor agonist (GLP-1RA) designed for the treatment of obesity, type-2 diabetes, and other cardiometabolic conditions. Initial results from the Phase … Read the full press release
Posted in Business, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, Cardiometabolic Conditions, ECC5004, Eccogene, Exclusive License, Jingye Zhou, Obesity, Oral GLP-1RA, partnership, Sharon Barr, sustainability, type 2 diabetes
(IN BRIEF) Roche, a leading healthcare company, has announced that its Elecsys Neurofilament Light Chain (NfL) test for Multiple Sclerosis (MS) has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). The Elecsys NfL test is designed … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged Elecsys NfL Test, FDA, Matt Sause, multiple sclerosis, Roche
(IN BRIEF) Health Canada has granted authorization for the probiotic strain Lactobacillus acidophilus DDS-1® to make health claims related to the gut-brain axis. The strain is now approved to help alleviate perceived stress, improve irritable bowel syndrome (IBS)-related quality of … Read the full press release
Posted in Denmark, Food & Beverage, Healthcare, Pharma & Biotech, Science
Tagged Brain, Chr. Hansen, DDS-1®, digestive issues, gut, gut-brain axis, Health Canada, IBS, irritable bowel syndrome, L. acidophilus, Linda Neckmar, mental well-being, microbiome, Natural Health Product, Niklas Larsson PhD, NPH license, probiotic strain, stress
(IN BRIEF) A recent study led by the Technical University of Munich (TUM) reveals that late-stage Parkinson’s disease patients may benefit from changes in treatment, even after invasive therapies have been attempted. The study analyzed data from 22 German Parkinson’s … Read the full press release
(IN BRIEF) The European Society of Cardiology (ESC) has issued a statement regarding the proposed Reform of the EU Pharmaceutical Legislation by the European Commission, currently in negotiation in the European Parliament and the Council. While the ESC supports the … Read the full press release
(IN BRIEF) Kuehne+Nagel, a global logistics company, has achieved its third consecutive IATA CEIV Pharma certification for its entire air logistics healthcare network. This milestone makes Kuehne+Nagel the first logistics company with over 100 CEIV Pharma-certified stations. IATA’s CEIV Pharma … Read the full press release
(IN BRIEF) BASF, a global chemical company, has entered into an innovation partnership with 3Helix Inc., a U.S.-based technology start-up, to leverage 3Helix’s proprietary CHP (Collagen Hybrid Peptides) technology. This collaboration involves an equity investment and licensing agreement, granting BASF … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Chemicals, Environment, Financial, Germany, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged 3Helix, Anti-Aging Technology, BASF, CHP technology, Dr. Marina Safont Sempere, INNOVATION, Mike Kirkness, partnership, sustainability
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
